TY - JOUR
T1 - Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus
AU - Fiorino, Gionata
AU - Caprioli, Flavio Andrea
AU - Onali, Sara
AU - Macaluso, Fabio Salvatore
AU - Bezzio, Cristina
AU - Armelao, Franco
AU - Armuzzi, Alessandro
AU - Baldoni, Monia
AU - Bodini, Giorgia
AU - Castiglione, Fabiana
AU - Daperno, Marco
AU - Festa, Stefano
AU - Furfaro, Federica
AU - Gionchetti, Paolo
AU - Leone, Salvatore
AU - Luglio, Gaetano
AU - Milla, Monica
AU - Mocci, Giammarco
AU - Napolitano, Daniele
AU - Orlando, Ambrogio
AU - Previtali, Enrica
AU - Pugliese, Daniela
AU - Renna, Sara
AU - Rispo, Antonio
AU - Saibeni, Simone
AU - Sampietro, Gianluca
AU - Savarino, Edoardo
AU - Scaldaferri, Franco
AU - Spagnuolo, Rocco
AU - Variola, Angela
AU - Viola, Anna
AU - Viscido, Angelo
AU - Vitale, Giovanna
AU - Zaetta, Debora
AU - Zingone, Fabiana
AU - Colli, Agostino
AU - Fantini, Massimo Claudio
PY - 2025
Y1 - 2025
N2 - Introduction: Inflammatory bowel disease (IBD) poses significant clinical challenges due to its chronic, disabling nature. Despite established guidelines, care standards remain inconsistent globally. In 2020, the European Crohn's Colitis Organisation (ECCO) developed quality-of-care standards. The Italian Group for the Study of IBD (IG-IBD) aimed to adapt those recommendations to Italy. Methods: A 42-member interdisciplinary panel used a Delphi consensus to evaluate and modify ECCO statements and levels of importance, incorporating patient representatives and regional experts. Those statements were revised, some missing statements were added, and a two-round voting session was held among participants. Agreement ≥80 % was needed to approve a statement. Results: From 101 ECCO statements, 112 tailored criteria were developed. In comparison to the ECCO statements, 80 were confirmed with the same level of importance, 9 were confirmed with different levels of importance, 9 points were merged in a broader statement, 3 points were dropped out during the two voting rounds, and 12 were added as new points. Conclusion: The adapted standards provide a framework for standardizing IBD care in Italy. This model might help other countries in aligning with ECCO standards.
AB - Introduction: Inflammatory bowel disease (IBD) poses significant clinical challenges due to its chronic, disabling nature. Despite established guidelines, care standards remain inconsistent globally. In 2020, the European Crohn's Colitis Organisation (ECCO) developed quality-of-care standards. The Italian Group for the Study of IBD (IG-IBD) aimed to adapt those recommendations to Italy. Methods: A 42-member interdisciplinary panel used a Delphi consensus to evaluate and modify ECCO statements and levels of importance, incorporating patient representatives and regional experts. Those statements were revised, some missing statements were added, and a two-round voting session was held among participants. Agreement ≥80 % was needed to approve a statement. Results: From 101 ECCO statements, 112 tailored criteria were developed. In comparison to the ECCO statements, 80 were confirmed with the same level of importance, 9 were confirmed with different levels of importance, 9 points were merged in a broader statement, 3 points were dropped out during the two voting rounds, and 12 were added as new points. Conclusion: The adapted standards provide a framework for standardizing IBD care in Italy. This model might help other countries in aligning with ECCO standards.
KW - Crohn's disease
KW - Inflammatory bowel disease
KW - Quality of care
KW - Standards
KW - Ulcerative colitis
KW - Crohn's disease
KW - Inflammatory bowel disease
KW - Quality of care
KW - Standards
KW - Ulcerative colitis
UR - https://publicatt.unicatt.it/handle/10807/312380
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105001878806&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105001878806&origin=inward
U2 - 10.1016/j.dld.2025.03.010
DO - 10.1016/j.dld.2025.03.010
M3 - Article
SN - 1590-8658
SP - N/A-N/A
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - N/A
ER -